Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study - Vicart, Savine; Franques, Jérôme; Bouhour, Françoise; Magot, Armelle; Péréon, Yann; Sacconi, Sabrina; Nadaj-Pakleza, Aleksandra; Behin, Anthony; Zahr, Noël; Hézode, Marianne; Fournier, Emmanuel; Payan, Christine; et al. (Neuromuscular disorders : NMD, 2021)
Keywords: Adult; Aged; Clinical trials; Cross-Over Studies; Double-Blind Method; Female; Humans; Life Sciences; Male; Mexiletine; Mexiletine - therapeutic use; Middle Aged; Muscle channelopathy; Myotonia - drug therapy; Myotonia congenita; Myotonia Congenita - drug therapy; Myotonic Disorders - drug therapy; Neurons and Cognition; Nondystrophic myotonias; Paramyotonia congenita; Quality of Life; Treatment Outcome; Clinical trials; Paramyotonia congenita; Nondystrophic myotonias; Myotonia congenita; Mexiletine; Muscle channelopathy